May 01, 2026
1:100
For every 100 shares held, investors received 1. The price per share adjusted from $0.00 to $0.20.
The split itself did not change the total investment value.
Chimeric Therapeutics Limited (ASX:CHM) operates in the Biotechnology industry.
Chimeric Therapeutics Limited company overviewChimeric Therapeutics Limited's most recent stock split was on May 1, 2026. It was a 1-for-100 reverse split, so shareholders received 1 share for every 100 they held.
Chimeric Therapeutics Limited (ASX:CHM) has split its stock 3 times: a 83-for-80 split on February 23, 2022, a 21-for-20 split on March 20, 2025, and a 1-for-100 reverse split on May 1, 2026.
Chimeric Therapeutics Limited has split its stock 3 times. This history records 3 splits between February 23, 2022 and May 1, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Chimeric Therapeutics Limited's 1-for-100 reverse split on May 1, 2026, every 100 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Chimeric Therapeutics Limited has not announced a new split in our records. Its most recent split was on May 1, 2026, less than a year ago. Companies announce splits in advance, and any new ASX:CHM split will appear on this page.
Already premium?